Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1981 Oct;36(10):774–780. doi: 10.1136/thx.36.10.774

Penetration of piperacillin into bronchial mucosa and sputum.

G E Marlin, K R Burgess, J Burgoyne, G R Funnell, M D Guinness
PMCID: PMC471753  PMID: 6460337

Abstract

Bronchial mucosal biopsies were obtained during fibreoptic bronchoscopy in 12 patients receiving a new semisynthetic penicillin, piperacillin. The piperacillin levels estimated in bronchial mucosa exceeded those required to eradicate organisms associated with acute bronchitis, Haemophilus influenzae and Streptococcus pneumoniae, and compared favourably with those required for activity against a wide variety of anaerobic and Gram-negative organisms including Pseudomonas aeruginosa. Sputum and serum piperacillin levels were obtained from eight patients with bronchial disease receiving a five to seven day course (8 to 16 g/day). Sputum/serum level ratios were constant for the two dosages (10.7% for 8 g/day; 14.3% for 16 g/day) suggesting a diffusion transfer process, although the presence of pus in the sputum appeared to facilitate penetration. Seven patients achieved sputum levels exceeding those required for activity against Haemophilus influenzae and Streptococcus influenzae, and four for Pseudomonas aeruginosa. This study provides pharmacolinetic support of the use of piperacillin in bronchopulmonary infection.

Full text

PDF
774

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Batra V. K., Morrison J. A., Lasseter K. C., Joy V. A. Piperacillin kinetics. Clin Pharmacol Ther. 1979 Jul;26(1):41–53. doi: 10.1002/cpt197926141. [DOI] [PubMed] [Google Scholar]
  2. Bodey G. P., Le Blanc B. Piperacillin: in vitro evaluation. Antimicrob Agents Chemother. 1978 Jul;14(1):78–87. doi: 10.1128/aac.14.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Campbell M. J. Tetracycline levels in bronchial secretions. J Clin Pathol. 1970 Jul;23(5):427–434. doi: 10.1136/jcp.23.5.427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Fu K. P., Neu H. C. Piperacillin, a new penicillin active against many bacteria resistant to other penicillins. Antimicrob Agents Chemother. 1978 Mar;13(3):358–367. doi: 10.1128/aac.13.3.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gartmann J. Doxycycline concentrations in lung tissue, bronchial wall, and bronchial secretions. Chemotherapy. 1975;21 (Suppl 1):19–26. doi: 10.1159/000221888. [DOI] [PubMed] [Google Scholar]
  6. George W. L., Lewis R. P., Meyer R. D. Susceptibility of cephalothin-resistant gram-negative bacilli to piperacillin, cefuroxime, and other selected antibiotics. Antimicrob Agents Chemother. 1978 Mar;13(3):484–489. doi: 10.1128/aac.13.3.484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hartnett B. J., Marlin G. E. Doxycycline in serum and bronchial secretions. Thorax. 1976 Apr;31(2):144–148. doi: 10.1136/thx.31.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Kroening U., Liebig S., Wundschock M. Tobramycin-Spiegel im menschlichen Lungengewebe. Infection. 1978;6(5):231–235. doi: 10.1007/BF01642315. [DOI] [PubMed] [Google Scholar]
  9. Liss R. H., Norman J. C. Visualization of doxycycline in lung tissue and sinus secretions by fluorescent techniques. Chemotherapy. 1975;21 (Suppl 1):27–35. doi: 10.1159/000221889. [DOI] [PubMed] [Google Scholar]
  10. Marks M. I., Prentice R., Swarson R., Cotton E. K., Eickhoff T. C. Carbenicillin and gentamicin: pharmacologic studies in patients with cystic fibrosis and pseudomonas pulmonary infections. J Pediatr. 1971 Nov;79(5):822–828. doi: 10.1016/s0022-3476(71)80401-8. [DOI] [PubMed] [Google Scholar]
  11. Marlin G. E., Davis P. R., Rutland J., Berend N. Plasma and sputum erythromycin concentrations in chronic bronchitis. Thorax. 1980 Jun;35(6):441–445. doi: 10.1136/thx.35.6.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McGowan J. E., Jr, Terry P. M. Susceptibility of gram-negative aerobic bacilli resistant to carbenicillin in a general hospital to piperacillin and ticarcillin. Antimicrob Agents Chemother. 1979 Jan;15(1):137–139. doi: 10.1128/aac.15.1.137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Meade J. B., Whitwell F., Bickford B. J., Waddington J. K. Primary haemangiopericytoma of lung. Thorax. 1974 Jan;29(1):1–15. doi: 10.1136/thx.29.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Monif G. R., Clark P. R., Shuster J. J., Baer H. Susceptibility of the anaerobic bacteria, group D streptococci, Enterobacteriaceae, and Pseudomonas to semisynthetic penicillins: carbenicillin, piperacillin, and ticarcillin. Antimicrob Agents Chemother. 1978 Nov;14(5):643–649. doi: 10.1128/aac.14.5.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Stewart S. M., Fisher M., Young J. E., Lutz W. Ampicillin levels in sputum, serum, and saliva. Thorax. 1970 May;25(3):304–311. doi: 10.1136/thx.25.3.304. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Tjandramaga T. B., Mullie A., Verbesselt R., De Schepper P. J., Verbist L. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration. Antimicrob Agents Chemother. 1978 Dec;14(6):829–837. doi: 10.1128/aac.14.6.829. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ueo K., Fukuoka Y., Hayashi T., Yasuda T., Taki H., Tai M., Watanabe Y., Saikawa I., Mitsuhashi S. In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1977 Oct;12(4):455–460. doi: 10.1128/aac.12.4.455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Verbist L. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob Agents Chemother. 1978 Mar;13(3):349–357. doi: 10.1128/aac.13.3.349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. White G. W., Malow J. B., Zimelis V. M., Pahlavanzadeh H., Panwalker A. P., Jackson G. G. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. Antimicrob Agents Chemother. 1979 Apr;15(4):540–543. doi: 10.1128/aac.15.4.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Winston D. J., Murphy W., Young L. S., Hewitt W. L. Piperacillin therapy for serious bacterial infections. Am J Med. 1980 Aug;69(2):255–261. doi: 10.1016/0002-9343(80)90386-1. [DOI] [PubMed] [Google Scholar]
  21. Winston D. J., Wang D., Young L. S., Martin W. J., Hewitt W. L. In vitro studies of piperacilin, a new semisynthetic penicillin. Antimicrob Agents Chemother. 1978 Jun;13(6):944–950. doi: 10.1128/aac.13.6.944. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES